Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Not good.
Shareholders receive $.028 per share.
As I post...
AVNR is at its 50 day MA. On a short term basis, it's overbought. But this type of stock is often news driven. So for the time being, I would say a bottom is in place and a small correction would not surprise me.
For what it's worth...
my best and most reliable technical indicator gave a buy signal today.
Interesting read.
Last year the US Navy bought 59,000 counterfeit microchips from China. The chips also contained a 'trojan horse' which would allow the chips to be shut down or disabled by a third party.
I hope the management of APDN knows how to take advantage of this major opportunity.
Three questions.
Why no PR on what appears to be the biggest development in the company's history?
Does the company have the money or access to the money to actually install the displays?
Any idea as to what annual revenue each display can produce?
Just an observation.
There is a critical mass number to the prescriptions. I don't know what that number is or whether it will be reached. But at $4 a share, I can be a long term holder of AVNR with minimal downside risk. Any company which has a drug in production and has a monopoly for that condition with other uses down the line is a strong hold at these levels while we see if management can deliver on the potential.
Occasionally there is a post which makes reading these boards all worth while. I may not agree with everything you have written but I certainly commend you for your thoughtfullness.
I hope management is up to the task of maximizing this perfect opportunity. Oil price trending up and environmental concerns over petroleum based plastics. This should be a no-brainer. But all business endeavors have human risks.
Question...is the PR accurate that CERP will be shipping 100-150 metric tons every month beginnging in December? If true that is a HUGE number and is a blockbuster of a contract.
Sheff, with all due respect, I'm long ALXA but I also think it's important to know all points of view. The article by gekko is not bashing ALXA but tries to present an objective review.
ALXA...both gekkowire.com and thecleverbull.com have new articles about ALXA. The gekko article is of great interest in that he explains in detail the pitfalls that ALXA faces in getting its delivery system approved.
ALXA and AVNR are beginning to see some accumulation in anticipation of October FDA approvals. One would think this would gather momentum as the approval dates draw closer. However, the overall economy and market has investors very skittish about speculative stocks.
ALZA...excellent review today in the Daily Pharma Watch. Covers the pros and cons of the stock offering and the risks going forward as we await the FDA approval.
ALXA...stock offering to institutional investors. Appears to be fairly priced IMO but shorts will cry dilution and try to force a negative reaction.
OPSY...just took a look at the technicals. Not too bad. Certainly a bottom play. Any type of legitimate news will give this a boost above $.02 or more.
DCTH...first I'm a long term holder and believer in its system. Second, my opinion and $4 will get you a cup of coffee at Starbucks. But it looks as if a bottom is in and I would be surprised if this doesn't double by the end of the year. Lots of current misinformation will give way to the realities of a game changer for liver cancer.
ONCO...to me what is most important in today's PR is that the contract is with the UPMC. It's one of the leading treatment centers for cancer in this country. ONCO is now a very valid entity and is a strong buy AND hold at these levels.
ETLS...picked up by PSC just a few minutes ago.
Good or bad?
GWTR...is now an official pick of the GURU. He has a large following which is well deserved. Good luck to all.
FYI...the Guru still rates KNOS a buy at this time.
CHSH...I wouldn't give up on this shell. Traders much better than I am are still in or lurking. There may be positive surprises in the not so distant future.
The Guru's write-up was even more effussive and positive than I anticipated.
I've already been privately chastised for mentioning the upcoming blog posting. So you will just have to speculate.
Look for a HOT penny stock picker to have positive, public comments about KNOS in his blog this evening. He was early and right on VCTY.
TTNP...fairly important news. First Eagle Investment Management took a $16M position in the company. It now owns about 13% which is enough that it will want to be involved with the management probably with a seat on the board of directors. It is a very positive development.
MSBT...my take is that Dr. Chan is getting the word out in interviews prior to the results of the trial in Germany. I doubt he would be doing so if the reslts were less than satisfactory. Clearly his efforts are building momentum.
EVRN...thanks for posting the video. Legitimate product with potential. Nerdy CEO is good in that he appears honest and sincere. The two major issues are financing and marketing. But it is well worth the investment at these levels.
TTNP...it's certainly been under consistent, but quiet, accumulation. Without news, a steady climb above $3 does not seem unreasonable.
Ms. Bloom may be a wonderful person. But she runs this company as her own private domain. My guess is that, if their are any profits, they are paid to Ms. Bloom is the form of salary and other benefits.
What the shareholders need is for an aggressive corporate attorney to get involved and remind Ms. Bloom that she has violated many fiduciary duties and responsibilities. Until that happens, the stock price is going to continue to languish regardless of the hopes and dreams of others.
Reverse split effective Monday.
Please share with the board the source of your information that big news is coming soon.
Take it for what it is worth, but my highly accurate and proprietary stock signal (LOL) is about to give a buy signal. It should mean a trend to the upside is underway. Let's see what happens.
For what it's worth, my own technical indicator gave a sell signal in mid-March close to $.34 and that sell signal remains in effect.
WSCE's management has squandered all its credibility and so, even with good news, this stock remains stuck in its own mire.
I would be more impressed if D'Amelio stepped up and bought in the open market. He's the key player for the medical instruments.
Markets abhor a vacuum. I'm not a big conspiracy person. But DR, with more to lose than anyone, has by his silence allowed CTGI to drift into almost oblivion. I'm also not pleased by the curt manner with which he addresses shareholder inquiries. I will go down with ship but the lack of shareholder concern from management is probably indicative of a company that is, for all practical purposes, finished. To me the early sign of failure was D'Amelio never buying any shares. He was the one person who had the perspective to know if there was a probability of success.
Give credit where credit is due. Jagman, you were right.
Took a quick look at the charts and a case can be made that VOYT has put in a long term bottom.
Not a lot of discussion about VOYT on the various blogs. Investor Village has the most activity and it's mainly bashers and supporters arguing with one another.
As a 'roll the dice' stock, VOYT is probably as good as you can do in this market environment.
My guess is that any purchase under 10 cents will be profitable.
This looks as if it is getting some legs for 2009.
If significant news is coming shortly, I would not look for any insider purchases since to do so is a SEC violation.
On the other hand, if insiders do buy it may be a sign that sales are not close at hand.
I have consistently suggested that shareholders not become fixated on any news in January in that meeting that deadline in this economic climate is unrealistic.
Regardless of who is responsible for last night's snafu, shouldn't Equitrend have issued a brief PR announcing the interview? Likewise, shouldn't Equitrend now issue a PR explaining the snafu and indicating when the interview will be rescheduled?